India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports
22/07/2026 05:24
BUZZ-India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports ** India's pharma stocks fall in morning trading
** U.S. President Donald Trump says imported generic drugs will remain tariff-free for two years from August 1, before tariffs increase to 100% for one year and 200% thereafter
** Nifty Pharma Index .NIPHARM down 1.01% amid a 0.7% decline in Nifty 50 Index .NSEI
** Shares of Aurobindo Pharma ARBN.NS down 2.9%, Sun Pharmaceutical SUN.NS down 1.2%, Cipla CIPL.NS down 2%, Lupin LUPN.NS falls 3%, Glenmark Pharmaceuticals GLEN.NS dips 2.6%
** Shares of Dr. Reddy's Laboratories REDY.NS fall 1.4%, Zydus Lifesciences ZYDU.NS down 2.4% and Torrent Pharmaceuticals TORP.NS down 0.8%
(Reporting by Abhinav Parmar in Bengaluru)
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11